98%
921
2 minutes
20
Background: Cardioneuroablation (CNA) treats reflex syncope by ablating ganglionated plexi (GPs) either confined to the right (RA) or left atrium (LA), or accessible from both. We assessed whether GP ablation in one atrium affects parasympathetic modulation in the other and how ablation sequence (RA then LA, or vice-versa) impacts efficacy.
Methods: Two propensity-matched groups of patients with reflex syncope or functional bradycardia were analyzed. Group 1 received CNA in the RA first, followed by LA. Group 2 in the reverse order.
Results: Thirty-four patients were enrolled. In group 1, RA ablation prompted a heart rate (HR) increase (49.8 ± 10.6 vs. 61.2 ± 13.8 bpm; p < 0.01) that was enhanced after LA ablation (60.3 ± 14.5 vs. 64.5 ± 14.4 bpm; p = 0.02). RA ablation did not reduce PR interval in any patient or modify the Wenckebach point (WP) (596 ± 269 vs. 609 ± 319 ms; p = 0.68), while additional LA ablation reduced PR interval in 3 patients and mean WP (611 ± 317 vs. 482 ± 191 ms; p = 0.03). In group 2, LA ablation increased HR (56.7 ± 6.6 vs. 76.4 ± 13.8 bpm; p < 0.01), with an additional effect of RA ablation (76.0 ± 16.5 vs. 85.4 ± 15.9 bpm; p < 0.01). LA ablation decreased PR interval in 3 patients and mean WP (512 ± 182 vs .399 ± 85 ms; p = 0.01). Further RA ablation did not decrease PR or WP. CNA success was 82% in group 1 and 100% in group 2 (p = 0.552). After 24.5 ± 6.1 months, 2 patients in group 1 vs. no patients in group 2 experienced symptom recurrence.
Conclusions: Bi-atrial CNA provides incremental benefits after both RA and LA ablation. Starting ablation in the LA provides the most significant effect on vagal modulation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10840-024-01968-8 | DOI Listing |
JACC Case Rep
September 2025
Cardiology Department, CHU Clermont-Ferrand, Clermont-Ferrand, France; Université Clermont Auvergne, CHU Clermont-Ferrand, CNRS, SIGMA Clermont, Institut Pascal, Clermont-Ferrand, France.
Background: Cardiac syncope due to sinus arrest may result from either a vasovagal cardioinhibitory mechanism or an intrinsic sinus node dysfunction.
Case Summary: A 67-year-old woman with a recently diagnosed right hilar mass presented with new-onset episodes of syncope associated with sinus arrest. Resting electrocardiogram was normal, and no electrolyte abnormalities were identified.
Europace
August 2025
Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
Background And Aims: Persistent atrial fibrillation (AF) ablation success rates remain limited. The aim was to evaluate the impact of ganglionated plexi (GP) ablation on AF mechanisms and outcomes in patients with low scar burden.
Methods: Patients undergoing persistent AF ablation were included.
J Am Heart Assoc
August 2025
Division of Cardiology, Department of Medicine Nihon University School of Medicine Tokyo Japan.
Background: Ganglionated plexi (GPs) within epicardial adipose tissue (EAT) are involved in the initiation and maintenance of atrial fibrillation (AF), yet the effects of catheter ablation on EAT volume and GP activity remain unclear.
Methods: A prospective 2-part study was conducted. Study 1 included 120 patients undergoing initial AF ablation, with pre- and 1-year postablation computed tomography used to assess changes in EAT and left atrial wall characteristics.
Eur Heart J Case Rep
July 2025
Medizinische Klinik I, Klinikum Fürth, Academic Teaching Hospital of the Friedrich-Alexander-University Erlangen-Nürnberg, Jakob-Henle Str. 1, Fürth 90766, Germany.
Background: Cardioneuroablation (CNA) has emerged as a promising therapeutic alternative to conventional pacing therapy for vasovagal syncope (VVS). Accurate patient selection and diagnosis are crucial for achieving optimal outcomes. The lack of a universally accepted protocol specifically tailored for selecting patients for CNA presents a gap in the current guidelines.
View Article and Find Full Text PDFBiomedicines
July 2025
Department of Anesthesiology and Perioperative Medicine, University of Pittsburgh, Pittsburgh, PA 15261, USA.
This review explores current and emerging neuromodulation techniques targeting the cardiac autonomic nervous system for the treatment and prevention of atrial and ventricular arrhythmias. Arrhythmias remain a significant cause of morbidity and mortality, with the autonomic nervous system playing a crucial role in arrhythmogenesis. Interventions span surgical, pharmacological, and bioelectronic methods.
View Article and Find Full Text PDF